Related Experiment Video
Updated: Dec 22, 2025
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
20.9K
Sentinel lymph node biopsy for high-thickness cutaneous squamous cell carcinoma
Lukas Kofler1, Katrin Kofler2, Claudia Schulz1
1Department of Dermatology and Center for Dermatologic Surgery, Eberhard-Karls University of Tuebingen, Liebermeisterstraße 25, 72076, Tübingen, Germany.
Archives of Dermatological Research
|May 10, 2020
Summary
Sentinel lymph node biopsy (SLNB) in high-risk squamous cell carcinoma did not significantly improve metastasis detection or survival outcomes compared to standard observation. The study found no difference in metastasis rates or tumor-specific death between groups.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Squamous cell carcinoma (SCC) is a common skin tumor with variable metastasis risk.
- Sentinel lymph node biopsy (SLNB) is a method to assess locoregional lymph node status in high-risk SCC.
- Accurate staging is crucial for patient prognosis and treatment planning.
Purpose of the Study:
- To analyze the role of SLNB in determining lymph node status for high-risk SCC patients.
- To evaluate the impact of SLNB on the incidence of further metastasis and tumor-specific survival.
- To compare outcomes between patients undergoing SLNB and those under observation.
Main Methods:
- Retrospective analysis of 720 high-risk SCC patients (tumor thickness > 5 mm).
- Comparison between 101 patients with successful SLNB and 570 patients in an observation group without histologic confirmation of lymph node status.
- Follow-up examinations to assess metastasis and survival.
Main Results:
- Overall lymph node metastasis rate was 11.11%, with no significant difference between the SLNB group (11.9%) and observation group (11.4%).
- Metastasis was found in the sentinel lymph node in 3.96% of SLNB patients.
- No significant differences in distant metastasis rates or tumor-specific death were observed between the groups.
Conclusions:
- While SLNB is technically feasible for assessing lymph node status in high-risk SCC, this study did not demonstrate a survival benefit.
- The current data suggest SLNB does not significantly alter outcomes regarding further metastasis or tumor-specific survival in this patient cohort.
- Further research may be needed to identify specific subgroups that could benefit from SLNB.
